These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 35413782)

  • 21. DMAP: a connectivity map database to enable identification of novel drug repositioning candidates.
    Huang H; Nguyen T; Ibrahim S; Shantharam S; Yue Z; Chen JY
    BMC Bioinformatics; 2015; 16 Suppl 13(Suppl 13):S4. PubMed ID: 26423722
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The assessment of efficient representation of drug features using deep learning for drug repositioning.
    Moridi M; Ghadirinia M; Sharifi-Zarchi A; Zare-Mirakabad F
    BMC Bioinformatics; 2019 Nov; 20(1):577. PubMed ID: 31726977
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug repositioning for psychiatric and neurological disorders through a network medicine approach.
    Lüscher Dias T; Schuch V; Beltrão-Braga PCB; Martins-de-Souza D; Brentani HP; Franco GR; Nakaya HI
    Transl Psychiatry; 2020 May; 10(1):141. PubMed ID: 32398742
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug Repositioning to Accelerate Drug Development Using Social Media Data: Computational Study on Parkinson Disease.
    Zhao M; Yang CC
    J Med Internet Res; 2018 Oct; 20(10):e271. PubMed ID: 30309833
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug repositioning in SLE: crowd-sourcing, literature-mining and Big Data analysis.
    Grammer AC; Ryals MM; Heuer SE; Robl RD; Madamanchi S; Davis LS; Lauwerys B; Catalina MD; Lipsky PE
    Lupus; 2016 Sep; 25(10):1150-70. PubMed ID: 27497259
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DrugNet: network-based drug-disease prioritization by integrating heterogeneous data.
    Martínez V; Navarro C; Cano C; Fajardo W; Blanco A
    Artif Intell Med; 2015 Jan; 63(1):41-9. PubMed ID: 25704113
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Novel Drug Repositioning Approach Based on Collaborative Metric Learning.
    Luo H; Wang J; Yan C; Li M; Wu FX; Pan Y
    IEEE/ACM Trans Comput Biol Bioinform; 2021; 18(2):463-471. PubMed ID: 31283509
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Computational drug repositioning through heterogeneous network clustering.
    Wu C; Gudivada RC; Aronow BJ; Jegga AG
    BMC Syst Biol; 2013; 7 Suppl 5(Suppl 5):S6. PubMed ID: 24564976
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biomedical data and computational models for drug repositioning: a comprehensive review.
    Luo H; Li M; Yang M; Wu FX; Li Y; Wang J
    Brief Bioinform; 2021 Mar; 22(2):1604-1619. PubMed ID: 32043521
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Computational Drug Repositioning with Random Walk on a Heterogeneous Network.
    Luo H; Wang J; Li M; Luo J; Ni P; Zhao K; Wu FX; Pan Y
    IEEE/ACM Trans Comput Biol Bioinform; 2019; 16(6):1890-1900. PubMed ID: 29994051
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Knowledge-driven drug repurposing using a comprehensive drug knowledge graph.
    Zhu Y; Che C; Jin B; Zhang N; Su C; Wang F
    Health Informatics J; 2020 Dec; 26(4):2737-2750. PubMed ID: 32674665
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In silico drug repositioning: what we need to know.
    Liu Z; Fang H; Reagan K; Xu X; Mendrick DL; Slikker W; Tong W
    Drug Discov Today; 2013 Feb; 18(3-4):110-5. PubMed ID: 22935104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Leveraging Big Data to Transform Drug Discovery.
    Glicksberg BS; Li L; Chen R; Dudley J; Chen B
    Methods Mol Biol; 2019; 1939():91-118. PubMed ID: 30848458
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Omics Data Integration and Analysis for Systems Pharmacology.
    Lim H; Xie L
    Methods Mol Biol; 2019; 1939():199-214. PubMed ID: 30848463
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inferring new drug indications using the complementarity between clinical disease signatures and drug effects.
    Jang D; Lee S; Lee J; Kim K; Lee D
    J Biomed Inform; 2016 Feb; 59():248-57. PubMed ID: 26707452
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heter-LP: A Heterogeneous Label Propagation Method for Drug Repositioning.
    Lotfi Shahreza M; Ghadiri N; Green JR
    Methods Mol Biol; 2019; 1903():291-316. PubMed ID: 30547450
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug repositioning for cancer in the era of AI, big omics, and real-world data.
    Wieder R; Adam N
    Crit Rev Oncol Hematol; 2022 Jul; 175():103730. PubMed ID: 35654244
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug repositioning of herbal compounds via a machine-learning approach.
    Kim E; Choi AS; Nam H
    BMC Bioinformatics; 2019 May; 20(Suppl 10):247. PubMed ID: 31138103
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of Computational Functional Genomics in Drug Discovery and Repurposing for Analgesic Indications.
    Lötsch J; Kringel D
    Clin Pharmacol Ther; 2018 Jun; 103(6):975-978. PubMed ID: 29350398
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Network medicine for disease module identification and drug repurposing with the NeDRex platform.
    Sadegh S; Skelton J; Anastasi E; Bernett J; Blumenthal DB; Galindez G; Salgado-Albarrán M; Lazareva O; Flanagan K; Cockell S; Nogales C; Casas AI; Schmidt HHHW; Baumbach J; Wipat A; Kacprowski T
    Nat Commun; 2021 Nov; 12(1):6848. PubMed ID: 34824199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.